Arch Biopartners Inc (ARCH.VN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [TSX Venture]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 09/30
(Values in thousands)
| 06-2025 | 03-2025 | 12-2024 | 09-2024 | 06-2024 | |
| Operating Expenses | 216 | 521 | 287 | 1,031 | 768 |
| Operating Income | -216 | -521 | -287 | -1,031 | -768 |
| Interest Expense | 59 | 67 | 70 | 117 | 95 |
| Other Income | 33 | -36 | -59 | 44 | -22 |
| Pre-tax Income | -242 | -624 | -416 | -1,104 | -885 |
| Net Income Continuous | -242 | -624 | -416 | -1,104 | -885 |
| Net Income | $-242 | $-624 | $-416 | $-1,104 | $-885 |
| EPS Basic Total Ops | 0.00 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Basic Continuous Ops | 0.00 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted Total Ops | 0.00 | -0.01 | -0.01 | -0.02 | -0.01 |
| EPS Diluted Continuous Ops | 0.00 | -0.01 | -0.01 | -0.02 | -0.01 |
| EBITDA(a) | $-183 | $-558 | $-346 | $-987 | $-789 |